Phase II study of oxaliplatin reintroduction treated with biweekly S-1 plus oxaliplatin (SOX) in patients with metastatic colorectal cancer.(ORION2)
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: Oxaliplatin 85 mg/m2, day1 S-1 80-120 mg/day, day 1-7 or alternate-day every 2 weeks Primary outcome(s): Progression free survival Study Design: Single arm Non-randomized
创建时间：
2014-03-15
